Sabby Management’s Cellectis CLLS Stock Holding History

Sabby Management’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-22,700	Closed	-$785K	–	333
2015 Q1	$785K	Buy	+22,700	New	+$824K	0.03%	210

Other funds holding CLLS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

GLG LLC New York $1.39B AUM 24.01% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return

Sabby Management's CLLS Position: Q2 2015 in Review

Sabby Management sold out of Cellectis (CLLS) in Q2 2015, closing a stake of 22,700 shares — an estimated $785K sold.

Sabby Management first reported a position in CLLS in Q1 2015 and held it in 1 quarter. The position peaked at $785K in Q1 2015. 40 funds tracked by Wall St. Rank hold CLLS as of Q2 2015.

Sabby Management reported no remaining Cellectis position as of Q2 2015 after selling out during the quarter.
Sabby Management sold 22,700 Cellectis shares in Q2 2015, an estimated $785K.
Sabby Management first reported a position in Cellectis in Q1 2015 and held it in 1 quarter.
Sabby Management's Cellectis position peaked at $785K in Q1 2015.
40 funds tracked by Wall St. Rank held Cellectis as of Q2 2015.

Based on Sabby Management's 13F filing for Q2 2015, filed 14 Aug 2015.